Studies on mechanisms of interferon-gamma action in pancreatic cancer using a data-driven and model-based approach
2011

How Interferon-Gamma Affects Pancreatic Cancer

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): Lange Falko, Rateitschak Katja, Fitzner Brit, Pöhland Ralf, Wolkenhauer Olaf, Jaster Robert

Primary Institution: University of Rostock

Hypothesis

IFNγ inhibits tumor progression through two mechanisms, reduction of fibrogenesis and antiproliferative effects on the tumor cells.

Conclusion

IFNγ is equally effective in DSL-6A/C1 tumors with and without stellate cells, suggesting its action may involve targeting additional cell types.

Supporting Evidence

  • IFNγ inhibited the growth of both types of tumors to a similar degree.
  • The presence of PSC accelerated tumor growth, but IFNγ treatment was still effective.
  • A mathematical model indicated that only a small fraction of STAT1 is activated in tumor cells upon IFNγ treatment.

Takeaway

Interferon-gamma helps slow down pancreatic cancer growth, even when the cancer cells are surrounded by supportive cells.

Methodology

The study used a mouse model and both in vivo and in vitro experiments to analyze the effects of IFNγ on pancreatic cancer cells and stellate cells.

Limitations

The study primarily focused on one type of pancreatic cancer cell line and may not generalize to all pancreatic cancers.

Participant Demographics

BALB/c-nu/nu mice were used in the experiments.

Statistical Information

P-Value

0.06

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-4598-10-13

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication